ReviewPharmaceutics2024

Poly (ADP-Ribose) Polymerase-1 (PARP-1) Inhibitors in Diabetic Retinopathy: An Attractive but Elusive Choice for Drug Development.

Etelka Pöstyéni et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.